![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 24585 |
FusionGeneSummary for NOP14-AS1_B2M |
![]() |
Fusion gene information | Fusion gene name: NOP14-AS1_B2M | Fusion gene ID: 24585 | Hgene | Tgene | Gene symbol | NOP14-AS1 | B2M | Gene ID | 317648 | 567 |
Gene name | NOP14 antisense RNA 1 | beta-2-microglobulin | |
Synonyms | C4orf10|RES4-24 | IMD43 | |
Cytomap | 4p16.3 | 15q21.1 | |
Type of gene | ncRNA | protein-coding | |
Description | NOP14 antisense RNA 1 (non-protein coding) | beta-2-microglobulinbeta chain of MHC class I moleculesbeta-2-microglobin | |
Modification date | 20180329 | 20180523 | |
UniProtAcc | P61769 | ||
Ensembl transtripts involved in fusion gene | ENST00000505731, ENST00000507999, ENST00000512712, ENST00000515194, ENST00000503709, ENST00000507702, ENST00000512802, | ENST00000558401, ENST00000559916, ENST00000544417, ENST00000559220, | |
Fusion gene scores | * DoF score | 3 X 3 X 1=9 | 14 X 19 X 3=798 |
# samples | 3 | 23 | |
** MAII score | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(23/798*10)=-1.79475488527797 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NOP14-AS1 [Title/Abstract] AND B2M [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | B2M | GO:0002726 | positive regulation of T cell cytokine production | 24643698 |
Tgene | B2M | GO:1900121 | negative regulation of receptor binding | 9465039 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | EL594117 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3UTR | ENST00000505731 | ENST00000558401 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000505731 | ENST00000559916 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000505731 | ENST00000544417 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000505731 | ENST00000559220 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000507999 | ENST00000558401 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000507999 | ENST00000559916 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000507999 | ENST00000544417 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000507999 | ENST00000559220 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000512712 | ENST00000558401 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000512712 | ENST00000559916 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000512712 | ENST00000544417 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000512712 | ENST00000559220 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000515194 | ENST00000558401 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000515194 | ENST00000559916 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000515194 | ENST00000544417 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000515194 | ENST00000559220 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000503709 | ENST00000558401 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000503709 | ENST00000559916 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000503709 | ENST00000544417 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000503709 | ENST00000559220 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000507702 | ENST00000558401 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000507702 | ENST00000559916 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000507702 | ENST00000544417 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000507702 | ENST00000559220 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000512802 | ENST00000558401 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000512802 | ENST00000559916 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-intron | ENST00000512802 | ENST00000544417 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
intron-3UTR | ENST00000512802 | ENST00000559220 | NOP14-AS1 | chr4 | 2945932 | - | B2M | chr15 | 45010021 | - |
Top |
FusionProtFeatures for NOP14-AS1_B2M |
![]() |
Hgene | Tgene |
NOP14-AS1 | B2M |
Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. | Component of the class I major histocompatibilitycomplex (MHC). Involved in the presentation of peptide antigens tothe immune system. Exogenously applied M.tuberculosis EsxA orEsxA-EsxB (or EsxA expressed in host) binds B2M and decreases itsexport to the cell surface (total protein levels do not change),probably leading to defects in class I antigen presentation(PubMed:25356553). {ECO:0000269|PubMed:25356553}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NOP14-AS1_B2M |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NOP14-AS1_B2M |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NOP14-AS1_B2M |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | B2M | P61769 | DB00254 | Doxycycline | Beta-2-microglobulin | small molecule | approved|investigational|vet_approved |
Top |
RelatedDiseases for NOP14-AS1_B2M |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | B2M | C0022658 | Kidney Diseases | 3 | CTD_human;HPO |
Tgene | B2M | C2609414 | Acute kidney injury | 2 | CTD_human |
Tgene | B2M | C0004364 | Autoimmune Diseases | 1 | CTD_human |
Tgene | B2M | C0018799 | Heart Diseases | 1 | CTD_human |
Tgene | B2M | C0020455 | Hypergammaglobulinemia | 1 | CTD_human |
Tgene | B2M | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | B2M | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | B2M | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
Tgene | B2M | C0079774 | Peripheral T-Cell Lymphoma | 1 | CTD_human |
Tgene | B2M | C0268389 | Amyloidosis, familial visceral | 1 | UNIPROT |
Tgene | B2M | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Tgene | B2M | C1855796 | Hypoproteinemia, Hypercatabolic | 1 | CTD_human;UNIPROT |